| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/23/2000 | CN1049588C Medicine for curing sleepless |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028084 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 02/22/2000 | US6028082 For trating psychological disorders |
| 02/22/2000 | US6028080 For treating neurological disorders |
| 02/22/2000 | US6028073 For treating psychoses |
| 02/22/2000 | US6028072 For treating inflammation and inflammation related disorders |
| 02/22/2000 | US6028070 Treating oppositional defiant disorder comprising administration to a patient in need of such treatment an effective amount of a norepinephrine reuptake inhibitor selective for norepinephrine over other neurotransmitters |
| 02/22/2000 | US6028063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 02/22/2000 | US6027927 Human trk receptors and neurotrophic factor inhibitors |
| 02/22/2000 | CA2199614C Fused indole and quinoxaline derivatives, their preparation and use |
| 02/22/2000 | CA2157248C Crystalline form of dihydro-2, 3 benzodiazepine derivative |
| 02/22/2000 | CA2002834C Cycloalkyl xanthines |
| 02/22/2000 | CA1340904C Amino acid derivative anticonvulsant |
| 02/22/2000 | CA1340902C Amino acid derivative anticonvulsant |
| 02/21/2000 | CA2280596A1 New indan-1-ol derivatives, their preparation method, and pharmaceutical compositions containing them |
| 02/18/2000 | CA2280455A1 The use of aryl-cyclohexylamine derivatives against cns disorders |
| 02/17/2000 | WO2000008192A2 Herpesviral vectors for gene delivery |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008143A2 Gene isolated on the short arm of human chromosome 17 |
| 02/17/2000 | WO2000008033A1 Water soluble prodrugs of hindered alcohols or phenols |
| 02/17/2000 | WO2000008020A2 Tricyclic carboxamides |
| 02/17/2000 | WO2000008017A1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride |
| 02/17/2000 | WO2000008013A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 02/17/2000 | WO2000008007A2 Cyclopentabenzofuran derivatives and their use |
| 02/17/2000 | WO2000008006A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 02/17/2000 | WO2000008004A1 Particle-forming compositions containing fused pyrrolocarbazoles |
| 02/17/2000 | WO2000008001A1 Substituted isoxazole as estrogen receptor modulators |
| 02/17/2000 | WO2000007997A1 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS |
| 02/17/2000 | WO2000007996A2 Pyrazoles as estrogen receptor modulators |
| 02/17/2000 | WO2000007995A1 SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 02/17/2000 | WO2000007994A1 Novel bi- and tri-cyclic aza compounds and their uses |
| 02/17/2000 | WO2000007988A1 New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same |
| 02/17/2000 | WO2000007986A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 02/17/2000 | WO2000007978A1 Aminomethylcarboxylic acid derivatives |
| 02/17/2000 | WO2000007977A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 02/17/2000 | WO2000007614A1 Remedies for nerve degeneration diseases |
| 02/17/2000 | WO2000007611A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 02/17/2000 | WO2000007600A1 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| 02/17/2000 | WO2000007592A1 Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis |
| 02/17/2000 | WO2000007583A2 Treatment of addiction and addiction-related behavior |
| 02/17/2000 | WO2000007570A1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 02/17/2000 | WO2000007569A1 Compressed compositions comprising clarified xanthan gum |
| 02/17/2000 | WO2000007568A1 Method for making coated gabapentine or pregabaline particles |
| 02/17/2000 | WO2000007542A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |
| 02/17/2000 | WO2000001815A3 Neurotrophic factors |
| 02/17/2000 | WO1999058116A3 Novel formulation containing paroxetine |
| 02/17/2000 | WO1999058113A3 Novel formulation containing paroxetine |
| 02/17/2000 | WO1999057241A9 Myelin basic protein peptides and uses thereof |
| 02/17/2000 | WO1999056763A9 Use of neglected target tissue antigens in modulation of immune responses |
| 02/17/2000 | WO1999055859A3 Cd40-interacting and traf-interacting proteins |
| 02/17/2000 | WO1999054310A3 New substituted amides, their production and their use |
| 02/17/2000 | WO1999053036A9 Ste20-related protein kinases |
| 02/17/2000 | WO1999044596A3 Glycine transport inhibitors |
| 02/17/2000 | WO1999015159A3 Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| 02/17/2000 | WO1999000346A8 Synthesis of dihydrohonokiol compositions |
| 02/17/2000 | DE19836697A1 New substituted 4-amino-2-aryl-pyrimidines, are soluble guanylate cyclase activators useful e.g. for treating atherosclerosis, hypertension, angina pectoris, thrombosis, asthma or diabetes |
| 02/17/2000 | DE19836406A1 New S,S-dioxobenzisothiazolinyl-substituted 3-azabicyclo (3.2.0) heptane derivatives, useful e.g. as neuroleptics, antidepressants, hypnotics and sedatives |
| 02/17/2000 | DE19836404A1 New benzimidazolonyl-substituted 3-azabicyclo (3.2.0) heptane derivatives, useful e.g. as neuroleptics, antidepressants, hypnotics and sedatives |
| 02/17/2000 | DE19830105C1 Acridinderivate Acridine |
| 02/17/2000 | CA2339857A1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride |
| 02/17/2000 | CA2339362A1 Tricyclic carboxamides |
| 02/17/2000 | CA2339122A1 Novel bi- and tri-cyclic aza compounds and their uses |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338944A1 Succinoylamino lactams as inhibitors of a.beta. protein production |
| 02/17/2000 | CA2338594A1 Imidazoles and related compounds as .alpha.1a agonists |
| 02/17/2000 | CA2338382A1 Herpesviral vectors for gene delivery |
| 02/17/2000 | CA2338173A1 Method for making coated gabapentine or pregabaline particles |
| 02/17/2000 | CA2337964A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 02/17/2000 | CA2305406A1 Pharmaceutical compounds |
| 02/16/2000 | EP0979870A1 Human Wnt-6 polypeptide |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979275A1 Novel human mago nashi protein |
| 02/16/2000 | EP0979240A1 Serine protease inhibitors |
| 02/16/2000 | EP0979238A1 Method of alleviating neuropathic pain |
| 02/16/2000 | EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| 02/16/2000 | EP0979095A2 Use of conantokins for producing analgesia or for neuroprotection |
| 02/16/2000 | EP0979092A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 02/16/2000 | EP0979087A1 Analgesic combination |
| 02/16/2000 | EP0979086A2 Method and composition for modulating amyloidosis |
| 02/16/2000 | EP0979083A2 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions |
| 02/16/2000 | EP0979073A1 Nitrosylation to inactivate apoptotic enzymes |
| 02/16/2000 | EP0642335B1 Controlled release preparation containing a salt of morphine |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244866A Imino-aza-anthracyclinone derivatives for the treatment of amyloidosis |
| 02/16/2000 | CN1244864A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 02/16/2000 | CN1244862A Endothelin antagonists: N-[[2'-[[4,5-dimethyl-3-isoxazolyl) amino] sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl] methyl] |
| 02/16/2000 | CN1244528A Di- Or triaza-spiral [4,5] decane derivative |
| 02/16/2000 | CN1244525A Substituted dihydropyridine dicarboxylic ester |
| 02/16/2000 | CN1244423A Vanilla powder and its preparation |
| 02/16/2000 | CN1244422A Pain relieving ointment and its preparation |
| 02/16/2000 | CN1244419A Naojinzhi oral liquor and its preparation |
| 02/16/2000 | CN1244415A Hemiplegia treating bolus |
| 02/16/2000 | CN1049431C Morpholine derivative and its use and medicinal prepration containing said derivatives |
| 02/16/2000 | CN1049336C Isoxazole derivatives for the treatment of irritable bowels system in preparing composition |
| 02/15/2000 | US6025493 For treatment of psychological disorders, alzheimer's disease, parkinson's disease, nervous system disorders |
| 02/15/2000 | US6025395 Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
| 02/15/2000 | US6025376 Chiral methylphenyloxazolidinones |
| 02/15/2000 | US6025374 Migraine |
| 02/15/2000 | US6025372 Somatostatin agonists |